Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2019-01-02 Report Publication Anno…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Finansiell kalender
Report Publication Announcement Classification · 99% confidence The document is titled 'Finansiell kalender' (Financial Calendar) and lists future reporting dates for Medistim ASA, including dates for the 'Halvårsrapport' (Half-year report), 'Ordinær generalforsamling' (Annual General Meeting), and quarterly reports (Q1, Q3). It is an announcement about the schedule of future corporate events and reports, not the reports themselves. Since there is no specific category for a 'Financial Calendar' or 'Reporting Schedule', and it is a general announcement regarding corporate events/reporting timelines, the most appropriate fallback category is Regulatory Filings (RNS), as it is a required disclosure about future events. However, given the specific mention of the 'Ordinær generalforsamling' (AGM) date, it is closely related to AGM information, but it is a schedule, not the meeting materials or results. Given the nature of announcing future reporting dates, RNS is the best fit as a general regulatory disclosure.
2019-01-02 Norwegian
Financial calendar
Report Publication Announcement Classification · 100% confidence The document is extremely short (446 characters) and explicitly titled 'Financial calendar'. It lists future reporting dates for the company, such as 'Half-yearly Report', 'Annual General Meeting', and 'Quarterly Report'. The concluding sentence states, 'Attached is the reporting dates for Medistim ASA in 2019.' This structure—a brief announcement detailing the schedule of future reports rather than containing the reports themselves—fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. It is not the actual Interim Report (IR) or AGM material, but the schedule for them.
2019-01-02 English
Innsider kjøper aksjer i Medistim ASA
Director's Dealing Classification · 99% confidence The document text is very short (236 characters) and reports a transaction involving a director/executive ('Leder for medisinsk avdeling', Anne Waaler) buying shares in the company (Medistim ASA). This directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'. The language is Norwegian, but the content clearly indicates insider trading activity.
2018-12-21 Norwegian
Insider purchases Medistim shares
Director's Dealing Classification · 99% confidence The document text explicitly states that an 'Insider purchases Medistim shares' and details a transaction by a member of the senior management ('Leader for Medical department in Medistim ASA, Anne Waaler'). This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). The document is very short, but the content is specific enough to classify it as DIRS rather than a general regulatory filing (RNS).
2018-12-21 English
Insider transfer og shares
Director's Dealing Classification · 99% confidence The document text explicitly mentions an 'Insider transfer og shares' involving a VP (Anne Waaler) selling and immediately purchasing shares. This activity directly relates to personal share transactions by company directors or executives (insider trading/dealing). This aligns perfectly with the definition for Director's Dealing (DIRS). The document is very short, but the content is specific enough to classify it directly rather than using the RPA/RNS fallback.
2018-12-19 English
Insider selger aksjer i Medistim
Director's Dealing Classification · 99% confidence The document text explicitly states that an 'Insider selger aksjer' (Insider sells shares) in Medistim ASA and details a transaction by a manager (Leder for medisinsk avdeling, Anne Waaler). This directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The appropriate code is DIRS.
2018-12-14 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.